Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 7, 2015; 21(9): 2719-2724
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2719
Table 2 Results in the 21 patients who received cyanoacrylate injections n (%)
No. of sessionsValue
142 (89.3)
25 (10.7)
≥ 30 (0)
mean no. of sessions1.1 ± 0.3
mean single aliquot of cyanoacrylate injection volume (mL) (range)0.3 ± 0.1 (0.1-0.5)
Successful hemostasis45 (95.7)/47 (95.7)
mean follow-up duration (mo)30.2 ± 25.5
Number of rebleeding episodes11 (52.4)/21 (52.4)
mean duration of hemostasis after EVO (mo)11.1 ± 11.6
Number of patients with rebleeding within < 12 m5 (23.8)/21 (23.8)
Treatment-related complications1 (4.8)/21 (4.8)